Stockscreener 앱 받기
1.44
7.69%
-0.12
시간 외 거래:
1.42
-0.02
-1.39%
전일 마감가:
$1.56
열려 있는:
$1.6
하루 거래량:
364.26K
Relative Volume:
0.07
시가총액:
$5.31M
수익:
$513.90K
순이익/손실:
$-48.50M
주가수익비율:
-0.0514
EPS:
-28.0101
순현금흐름:
$-28.99M
1주 성능:
-31.43%
1개월 성능:
-53.55%
6개월 성능:
-64.22%
1년 성능:
-87.42%
1일 변동 폭
$1.4101
$1.6412
1주일 범위
$1.38
$2.17
52주 변동 폭
$1.26
$13.54
Co Diagnostics Inc Stock (CODX) Company Profile
명칭
Co Diagnostics Inc
전화
(801) 438-1036
주소
2401 S FOOTHILL DRIVE, SALT LAKE CITY
Compare CODX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
1.44 | 7.52M | 513.90K | -48.50M | -28.99M | -28.01 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-12 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2021-12-29 | 개시 | Sidoti | Buy |
| 2021-03-29 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-05-20 | 업그레이드 | Maxim Group | Hold → Buy |
| 2020-05-18 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-09 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-03 | 다운그레이드 | Maxim Group | Buy → Hold |
모두보기
Co Diagnostics Inc 주식(CODX)의 최신 뉴스
CODX Looks 3.8% Undervalued on GF Value™ as Market Prices in Cha - GuruFocus
Co-Diagnostics Joint Venture CoSara provides Ebola Test Kits for analytical studies - BioSpectrum Asia
Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies - Yahoo Finance
EXCLUSIVE: Co-Diagnostics Announces Successful Proof of Concept for Extraction-Free Ebola Test - Benzinga
Co-Diagnostics, Inc. Announces Amendment to Equity Distribution Agreement with Maxim Group LLC – July 2026 SEC Filing Update – Minichart - Minichart
Co-DiagnosticsAmends Equity Distribution Agreement With Maxim Group For Common Stock SaleSEC Filing - TradingView
Co-Diagnostics Updates ATM With Maxim, Extends Share Standstill to Aug. 14, 2026 - TradingView
Co-Diagnostics Inc (CODX) Cash Flow - TradingKey
Why Did CODX Stock Nearly Double In Value Today? - Stocktwits
Co-Diagnostics Inc (CODX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Co-Diagnostics Inc (CODX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Co-Diagnostics Inc (CODX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Co-Diagnostics, Inc. Revenue Breakdown – MUN:C970 - TradingView
CODX|Co-Diagnostics Inc|Price:2.100|Chg%:-0.110 - TradingKey
Co-Diagnostics Inc (CODX) Balance Sheet - TradingKey
Co-Diagnostics Inc (CODX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Co-Diagnostics Inc (CODX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Co-Diagnostics, Inc. Revenue Breakdown – LS:A41UNJ - TradingView
CODX Stock Explodes Over 630% In Six Sessions – Retail Traders Bet The Rally Isn’t Over Yet - Stocktwits
Co-diagnostics(CODX) Stock Options Chain | Quotes & News - Moomoo
CODX: Co-Diagnostics Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Co-Diagnostics Inc (CODX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Co-diagnostics Company Profile & Introduction - Moomoo
CODX Stock Price, Quote & Chart - ChartMill
Co-Diagnostics joint venture begins TB test clinical studies in India By Investing.com - Investing.com South Africa
Co-Diagnostics joint venture begins TB test clinical studies in India - Investing.com Nigeria
Co-Diagnostics launches TB test clinical trials on PCR Pro devices in India labs - Pluang
Co-Diagnostics' India Joint Venture Launches Clinical Studies for Tuberculosis Test - marketscreener.com
About 30-Minute TB Test Enters Evaluation in Indian Labs - Stock Titan
EXCLUSIVE: Co-Diagnostics Marks New Milestone as India TB Test Clinical Studies Begin - Benzinga
Form DEF 14A CO-DIAGNOSTICS For: 21 July By Investing.com - Investing.com Nigeria
$2.45 | Co-Diagnostics, Inc. Common Stock (CODX) Stock Price Today - Binance
Co-Diagnostics names Wes Lindsey as chief scientific officer - Investing.com India
Co-Diagnostics names Wes Lindsey as chief scientific officer By Investing.com - Investing.com South Africa
Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer - Finviz
Co-Diagnostics Names New Chief; Co-Dx PCR Is Not Yet for Sale - Stock Titan
Form PRE 14A CO-DIAGNOSTICS For: 10 July By Investing.com - Investing.com South Africa
Co‑Diagnostics seeks shareholder approval to add 2.0M shares to equity plan | CODX SEC FilingForm PRE 14A - Stock Titan
Co-Diagnostics to show TB test platform at UN workshop in Bangkok - Stock Titan
Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand - PR Newswire
Why did CODX stock surge 45% in pre-market today? - MSN
OpenAI's Major Overhaul: Aiming for Growth Before IPO - GuruFocus
Co Diagnostics Inc (CODX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.04%
11.95%
자본화:
|
볼륨(24시간):